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Abstract
Adverse drug events (ADEs) are a significant problem in health care. While effective warnings have the potential to reduce
the prevalence of ADEs, little is known about how patients access and use prescription labeling. We investigated the
effectiveness of prescription warning labels (PWLs, small, colorful stickers applied at the pharmacy) in conveying warning
information to two groups of patients (young adults and those 50+). We evaluated the early stages of information
processing by tracking eye movements while participants interacted with prescription vials that had PWLs affixed to them.
We later tested participants’ recognition memory for the PWLs. During viewing, participants often failed to attend to the
PWLs; this effect was more pronounced for older than younger participants. Older participants also performed worse on the
subsequent memory test. However, when memory performance was conditionalized on whether or not the participant had
fixated the PWL, these age-related differences in memory were no longer significant, suggesting that the difference in
memory performance between groups was attributable to differences in attention rather than differences in memory
encoding or recall. This is important because older adults are recognized to be at greater risk for ADEs. These data provide a
compelling case that understanding consumers’ attentive behavior is crucial to developing an effective labeling standard
for prescription drugs.
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Introduction
Successful drug interventions require the production of a safe
and effective product, accurate prescribing, correct compounding
and dispensing, and finally, patient compliance and adherence.
Failure at any stage in the system has the potential to result in an
adverse drug event (ADE), defined as ‘‘injury due to medication
[1].’’ Adverse events in health care are increasingly recognized as
an important problem, because of both health ramifications and
cost [2,3].
In 1999, the Institute of Medicine identified medication errors
as a significant and preventable source of ADEs [4,5]. It has been
estimated that nearly 15 million medication errors occur annually
in the US, and that a majority of them are in the outpatient
setting, where it is up to the patient to use the information
provided to him or her about the drug [6]. Studies have indicated
that a considerable proportion of patients fail to comply with the
instructions received with prescription drugs [7,8]. Furthermore, it
has been noted that more complicated drug regimens are more
likely to result in an ADE. This would suggest potentially greater
risk of medication errors for seniors, who are documented to have
more complicated medical regimens than their younger counter-
parts [9].
The provision of timely information can play a part in
preventing ADE’s [10], and can range from sophisticated home
healthcare systems that employ technology and personnel, to
simple labels affixed on prescription drug vials. Medication labels
offer benefits over other approaches because they are affordable,
remain with the package for the longest time and are readily
accessible to the patient when needed [10,11]. As such, proper and
informative labeling is a promising and important tool in the
prevention of ADEs [6,10,11].
Pharmacists have attempted to capitalize on this potential by
placing prescription drug warning labels (PWLs- see Figure 1) on
drug vials. PWLs are small, colorful stickers that are affixed
directly to the vials upon dispensing. They contain warning
statements such as, ‘‘Do not consume alcohol while taking this
medication’’ or information about routes of administration such as
‘‘For external use only.’’ PWLs ‘‘were originally developed as a
quick reminder to highlight the most important instructions for the
safe and effective use of the medication.’’ [12] Conversely, failure
to heed these messages has the potential to result in an ADE.
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Therefore, it is surprising that the Federal government does not
regulate PWLs [12]. To date, there are no universal, federal
standards regarding the method of presentation or the information
conveyed by PWLs. Recognizing the need for consistent labeling
of prescription drugs, the US government has recently begun to
investigate approaches to standardizing the format and content of
prescription drug labeling and the effect such a move would have
on error rates [13,14].
Clearly, the ability to determine the maximal potential benefits
of a labeling protocol requires first identifying the optimal method
of delivery for labeling. That is, a PWL may be ineffective because
it is poorly designed, not because the approach of labeling
medicines with PWLs is inherently ineffective.
With this in mind, there has been research investigating ways to
alter PWL designs to improve their effectiveness. [5,15] However,
most of the research in this area has focused on consumers’ ability
to comprehend warning messages, concluding that it is important to
present messages in clear, simplified language and that the use of
pictorial icons may be beneficial, particularly to patients with low
literacy [16,17].
While research on label comprehension is clearly an important
characteristic of successful labeling, it ignores other aspects of
information processing that are also critical for a label to be
effective. For instance, to focus solely on comprehension presup-
poses that people will attend to warning labels and attempt to
comprehend them. Our earlier work [18] investigating warning
labels on the cartons of over the counter (OTC) drugs indicated
that a significant proportion of young adults (M=25, SD=6.3
years of age) never examined two warning labels that were required
by law to be prominent and conspicuous. Although OTC systems
are significantly different from the prescription vials studied here
(e.g. they tend to place more emphasis on marketing information),
if the same holds true for the prescription warnings studied herein,
it renders the question of whether or not the warning message is
comprehensible, moot. That is, in the context of an information
processing model [19,20] (see Table 1), a number of serial stages of
processing must occur (i.e. exposure, attention and encoding),
before comprehension becomes an issue.
Here, we focus on the early stages of the information processing
model using PWLs. In particular, we investigate how attentive
processes influence encoding and recognition memory of warning
labels, and how factors such as the label’s color influence attention
and encoding (stages 2 and 3- see Table 1). Additionally, given that
older patients have been identified as at particular risk from the
effects of ADEs [21–23], we are particularly interested in how
information processing might differ between young adults and
older consumers. Specifically, we assess whether the increased risk
of errors among the elderly might be due primarily to deficits in
encoding or memory (Table 1- Stage 3), or at least partially
attributable to differences in attentive behavior (Table 1- Stage 2).
The objectives of this study were: 1) To evaluate people’s
attention to PWLs using eye tracking; 2) To determine whether
varying the color of PWLs impacts the probability of noticing
them; 3) To investigate the relationship between attention and
memory for recently presented PWLs; 4) To determine whether
patterns of attention differ as a function of age and; 5) To
determine the extent to which differences in attention across age
groups can explain differences in recognition rates. By providing
insight into the processing of information contained within PWLs,
this study can inform debates about labeling designs that are most
likely to impact a wide age range of consumers.
To accomplish these objectives, each subject was presented with
five prescription vials, each containing a PWL in one of five color
combinations (see inset Figure 1a.), in a random order of
presentation. Eye tracking provided researchers with videos of a
subject’s field of view with a superimposed set of crosshairs that
indicated where a participant was looking. Analyzing these videos
provided information on which parts of the vials were visually
fixated by consumers, in what order people attended information,
how many times participants returned to varied information
segments and for how long. During analysis, the prescription drug
vial was separated into three mutually-exclusive ‘look zones’ (see
Figure 1b.) – the white pharmacy label, cap and PWL. These three
zones encompassed all printed information included on the vial.
While both the pharmacy label and PWLs contained important
textual information about taking the medication within the vial,
the cap served as a baseline condition that consisted of text not
relevant to medication usage, but relevant to the operation of the
vial.
In order to evaluate the attentional prioritization of label
features, we modeled two dependent variables: (a) the probability
of the eye ever fixating on or ‘‘hitting’’ a label zone, and (b) the
total number of gaze shifts directed to a label zone. The
probability of fixation is relatively intuitive as a dependent
variable. After all, a major objective of the study was to determine
whether (or not) patients looked at the PWL.
The use of the number of gaze shifts into a zone as a dependent
variable may warrant further explanation. We chose this variable
because it is a well-established index of the relative interest and
importance of a viewing area. That is, rather than using eye
movements to continually sample new information in a scene,
viewers tend to repeatedly fixate on previously viewed objects
when freely viewing a scene [24]. As Yarbus [25] noted, ‘‘…when
changing its points of fixation, the observer’s eye repeatedly
returns to the same elements… Additional time spent on
perception is not used to examine the secondary elements, but
to reexamine the most important elements.’’ (p. 193) This
phenomenon has been well documented in varied tasks [24]
including: reading [26,27], painting [28], problem solving [29],
sorting [30], picture viewing [31] and visual search [32]. Most
recently, Zelinsky et al. [24] have suggested this phenomenon to
be a visual form of memory ‘‘rehearsal’’ needed to attenuate rapid
declines in immediate memory for the important portions of a
stimulus. Finally, the total number of gaze shifts to unique zones
indexes how dynamic the search process is, with a high number of
total gaze shifts indicative of a very dynamic process and a low
number of total gaze shifts indicative of a more stationary process.
Figure 1. Actual vial used in this study depicting the three label
zones of interest 1a- (1) cap, (2) standard white pharmacy label and
(3) prescription warning label (PWL). (Inset: Five color contrasts of PWLs
used in this study) 1b- Flattened, scaled drawing.
doi:10.1371/journal.pone.0038819.g001
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Results
Subjects
A total of 33 subjects were recruited for the study. Researchers
failed to successfully calibrate one subject with the eye tracking
equipment, so data from 32 subjects was available for analysis.
Two age groups were tested, one consisting of young adults
(n = 15, 7 males, 8 females, age range of 20–29 with an average
age of 22.8 years) and a second, consisting of adults over the age of
50 (n= 17, 5 males, 12 females, age range of 51–77 with an
average age of 62.2 years). Additional information was collected
from the subjects regarding their highest level of education and
number of prescription drugs taken per day; they were further
characterized through the use of standardized tests that assessed
their ability to see color, their level of health literacy and their
visual acuity.
Supplementary data. Subjects from the older population
reported taking an average of 2.95 prescription drugs per day
(Range= 029), whereas the younger population reported an
average of only 0.4 per day (Range= 022). Only one member of
the older population was identified as at risk for inadequate health
literacy using the REALM-R test [33], in contrast to 4 members of
the younger population. All members of the younger population
were found to have normal red/green color vision using Pseudo
Isochromatic color plates, while two members of the older
population were found to be at risk for abnormal red/green color
vision.
Attentional Prioritization - Eye Tracking Data
The probability of fixating a label zone (a). Eye tracking
data were first analyzed based on a binary response variable (i.e.
fixated: yes, no) using a generalized linear mixed model, such that
the ‘‘probability of fixating’’ was estimated and compared between
label zones. The model included the fixed effects of population age
(younger vs. older), zone (PWLs, cap and white pharmacy label)
and their two-way interaction. The model also included the
random effect of subject nested within population age. Explana-
tory variables corresponding to health literacy, number of
prescription drugs per day, gender, ethnicity, age, order of
presentation of vials and visual acuity of the subject were included
in the statistical model during the initial stages of analysis, but were
later dropped based on no evidence of improved model fit as per
Bayesian Information Criteria and lack of statistical significance
(P-values .0.10).
A significant age group by label zone interaction was identified
on the probability of noticing a zone (P, 0.0088) (See Figure 2).
More specifically, the probability of noticing a PWL was lower for
the older (Estimated LSM 6 SEM 54.0%617.6%) relative to the
younger population (91.8%66.1%; P=0.0396); yet, no evidence
for age differences were apparent on the probability of noticing the
white prescription label (100.0%68.6E27% for the older
population and 100.0%63.3E27 for the younger population).
This was also true for the probability of noticing the cap; although
the relative probability of noticing the vial cap was decreased in
both populations, the decrease was more pronounced in the older
population (2.4%61.95%), when compared with the younger
(24.4%613.0%; 0.0197). Within the PWL, no effect of color was
evident on the probability of noticing (P= 0.9941).
On number of gaze shifts toward a label zone (b). The
number of gazes at a label zone was modeled using a generalized
linear mixed model with a Poisson distribution. The model
included the fixed effects of treatment, age group, their 2-way
interaction and the effects of gender and total time spent on the
vial. The effects of health literacy, number of prescription drugs
taken per day, ethnicity, age, order and visual acuity were also
considered but were not included in the final model due to lack of
statistical significance (P-values .0.10).
Table 1. Serial steps of a commonly recognized information processing model.
Step 1. Exposure: The information must be available for the patient to seek (either actively or passively)
Step 2. Attention: For an environmental stimulus to reach conscious awareness, it must be attended. Thus, an ideal
warning will ‘stand out’ and capture the user’s attention, ensuring that it is attended even in the face
of varied distractions.
Step 3. Encoding: The message must be extracted and encoded. The amount of cognitive resources required for the
successful encoding of a stimulus is dependent upon user characteristics (i.e, the amount of
cognitive capacity the individual user possesses), the information design (e.g., the legibility of the
message text and complexity of the wording) and the context of interaction (e.g. well-lit, calm).
Optimal informational design should reduce the required cognitive load associated with encoding
the meaning of the warning, thereby, increasing the likelihood of successful encoding.
Step 4. Comprehension: Through encoding, an ideal warning will be completely converted into retrievable information in the
user’s memory, enabling recall and recognition. Additionally, the intended message is
comprehended.
Step 5. Compliance: The intended message results in the appropriate action on the part of the viewer (i.e. compliance).
doi:10.1371/journal.pone.0038819.t001
Figure 2. Least Square Mean Estimates (across subjects) of
percentage of the probability of fixation by zone and age
group. Error bars represent the between subjects standard error.
doi:10.1371/journal.pone.0038819.g002
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This analysis revealed a significant main effect of label zone
(p,0.0001), with a greater number of gazes directed at the white
pharmacy label (1.3560.11), than the PWL (0.6860.07) (P,0.05).
Fewer gazes were directed at the cap (0.2060.04) compared to the
PWL (P,0.01). This finding replicates the binary probability zone
data previously discussed, and further suggests that the pharmacy
label is given the highest attentional prioritization, while PWLs are
given lower priority, and the cap is given the lowest priority.
A significant main effect of age group was also evident
(P = 0.0010), with the younger group making more total shifts
(0.8560.09) than older participants (0.476.06). This finding
suggests that young participants implement a more dynamic
attentional search comprised of more shifts of attention to different
label zones. By contrast, older viewers tend to implement a more
stationary process in which attention tends to shift zones
infrequently (see Figure 3).
After adjusting for age group, a significant effect of gender was
noted on the number of gaze shifts directed across all zones
(P = 0.0099). Women were noted to have significantly more gaze
shifts than their male counterparts (0.7760.08 vs. 0.5260.06,
respectively). This suggests that women may use more dynamic
search behaviors than men when seeking information from the
labels of their medications. This is consistent with previous work
that has indicated gender effects on hazard perception and
tendencies to look for warnings [34–36]. There is also research
that suggests that women are more likely to attend to warning
information than their male counterparts [34,37,38]. This may be
partially explained by the finding that men have a lower sense of
perceived hazardousness than women towards products that are
considered to be hazardous to both genders [36].
Recognition. After the eyetracking section of the study,
subjects were presented with a printed sheet of 10 labels, five of
them were the exact PWLs that they viewed on the vials and five
others with different colors but the same textual messages (see the
limitations section for a justification of this method). The binary
response of correctly identifying the PWLs (either correctly
recognized as observed or correctly rejected as not-observed
during the eye tracking study), was recorded for each subject and
modeled as a function of age group. In addition, the effects of
health literacy, number of prescription drugs per day, ethnicity,
age, gender and visual acuity were considered for model inclusion.
These explanatory variables did not make significant contribution
to model fit and were not included in the final model.
Recognition significantly differed between age groups
(p = 0.048). The probability of correctly identifying the PWLs as
seen was greater for the young (68.5%65.05%) than the older
(53.6%64.8%) participants.
Fixation contingent recognition. The findings that older
participants were less likely to view PWLs (see Figure 2), had fewer
gaze shifts to PWLs (see Figure 3), and were less likely to correctly
identify or reject the PWLs during the recognition memory test,
supports the serial nature of information processing (see Table 1);
i.e. that fixating on the information within the PWL is critical to its
further processing. This serial process suggests that the older
participants may have done worse in the recognition task, not
because of problems with memory, but simply because they were
less likely to attend to the PWLs during the initial viewing.
To investigate this possibility, we modeled the probability of
recognition as a function of previous fixation, accounting for age
groups. A generalized linear mixed model was fitted to the
response ‘‘number of labels recognized’’ (out of the possible five
presented during the eye tracking task) assuming a binomial
distribution and using a logit link function. The linear predictor on
the statistical model included the fixed effects of age group,
fixation during eye-tracking (yes/no) and their 2-way interaction.
Also included in the linear predictor was the random effect of
subject nested within age group to account for subject-specific
random perturbations on the binomial response explicitly.
This analysis revealed a significant main effect of fixation
(p = 0.017), with higher recognition rates for the fixated
(57.8%67.12%) than the non-fixated objects (15.35%66.8%)
across the populations (see Figure 4). After accounting for the
effect of fixation, no evidence for age differences in the probability
of recognition were apparent (P = 0.17). That is, the difference in
recognition between age groups may be attributable to differences
in attentional allocation during the view period.
Figure 4 presents the mean estimate percentages (across
subjects) of presented labels that were successfully recognized as
a function of age and conditional on whether the label was fixated
or not during free viewing. When subjects of either age group
fixated the PWL, recognition rates were fairly high (young adults
61.7%69.7% vs older adults 54.0%610.1%). Similarly, when
subjects from either age group failed to fixate the PWL,
recognition rates were low (young 23.9%614.5%; old
Figure 3. Least Square Mean Estimates of the number of gaze
shifts into a label zone by age and estimated standard errors
(whiskers).
doi:10.1371/journal.pone.0038819.g003
Figure 4. Estimated percentage of correctly recognized PWLs
contingent on fixation.
doi:10.1371/journal.pone.0038819.g004
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9.5%,65.0%). Regardless of age, subjects were more likely to
recognize the labels if they had fixated on them first (P = 0.0167).
After accounting for fixation, no evidence for age differences in the
probability of recognition were apparent (P = 0.17). Consequently,
the mean difference in overall recognition rates was explained by a
lower fixation rate amongst older participants.
Discussion
We tracked eye movements while participants interacted with
drug vials labeled with PWLs that are currently employed by
pharmacists. We then tested participants’ recognition memory for
the PWLs that they had been presented. This approach allowed us
to conclude that PWLs often fail to attract attention, that this
failure is more pronounced in older viewers, and this failure to
attend to PWLs is associated with poor recognition memory for
PWLs. These data have important implications for understanding
possible shortcomings of current PWLs. They provide insight into
a potential cause of age-related differences in PWL effectiveness,
and suggest that designers should, at least in part, focus on
attracting attention.
Presented evidence suggests that people often fail to attend to
PWLs; when handed five vials in succession, only 50% of
participants fixated on all five PWLs and 22% did not fixate on
ANY PWLs. This lack of attention is consequential, as a failure to
attend negatively impacts the ability of a PWL to be successfully
encoded and remembered. Attended items were correctly recog-
nized about 42% more often than unattended items, representing
a 275% increase in memory performance relative to the base
recognition rate for unattended items. As such, the findings
highlight the importance of considering how a PWL impacts
attention and suggests that the noted ineffectiveness of PWLs
[5,16,17] are not limited to difficulties comprehending warning
messages, but may begin earlier, with a failure to attend to the
warnings (see Table 1).
Our comparison across age groups also provides some insight
into the source of potential age-related differences in PWL
effectiveness. Specifically, we found that only 29% of our older
participants attended to all five of the PWLs, and another 29%
failed to fixate any of the PWLs. For younger viewers these
numbers were 73% and 13%, respectively. This dramatic
difference in attention between the older and younger participants
was accompanied by a lower PWL recognition rate in our older
participants. More interestingly, when we compared recognition
memory performance as a function of whether or not the PWL
was fixated during free viewing, these age-related differences in
memory performance were no longer significant. That is, both
younger and older participants had similar, fairly high recognition
memory for attended PWLs and similar, fairly low recognition
memory for unattended PWLs. This pattern of data suggests that,
at least with these brief retention intervals, the overall lower
memory rates for the older participants are attributable to their
failure to attend to the PWLs, rather than difficulties encoding and
recalling attended labels. The implication of these age-related
findings is that a label that is effective at attracting the attention of
older people may more effectively convey information critical to
the safe and effective use of medications in a population known to
be at risk for ADEs [22,23,39].
Taken in total, our data suggests that a focus of PWL design
should be to create PWLs that attract attention. How might one
design a PWL to increase attention? Our comparison of different
colored PWLs is relevant to this question. Across a variety of
colors, we found that PWL color did little to increase the
probability of it being noticed (P.0.70), or recognition of, the
PWL. This finding was somewhat surprising to us because the
presentation of a colored label should have increased the low-level
visual discrepancy of the warning labels relative to the rest of the
bottle. As a result, these colored labels should have been more
likely to stimulate the bottom-up or saliency based attentional
network [40]. The fact that increasing this bottom up signal did
not significantly increase attention to the labels suggest that
people’s attentive behaviors during the vial interactions were not
guided by the bottom-up system, but instead were guided more by
the top-down attentional system that directs attention to locations
and objects that are relevant to one’s current goals [41,42].
Consistent with this interpretation, all participants viewed the
white pharmacy label, indicating that people’s expectation was
that goal relevant information would be presented at that location.
This interpretation suggests that the placement of the PWLs as a
separate label that is spatially distinct from the white pharmacy
label may actually hinder the label’s ability to garner attention (i.e.
failure at step one: exposure). If the top-down attentional system is
guiding attention toward the white pharmacy label, placing
warning in that zone may prove to be more effective.
In conclusion, the standard types of PWLs that we tested here
were not effective in capturing attention, which resulted in low
recognition memory for the PWLs. In addition, these attentive
deficits, and corresponding recognition deficits, were particularly
acute in our older population, a population identified to be at
particular risk for the ill-effects associated with ADEs [22,23,39].
Importantly, our analysis suggested that these age-related recog-
nition deficits were attributable to failures to attend to the PWLs,
rather than other cognitive deficits associated with aging [43].
When older participants fixated PWLs, their ability to remember
the PWLs was equivalent to their younger counterparts. These
data strongly suggest that attempts to improve the effectiveness of
PWLs need to consider not only factors that impact later stages
within the stream of information processing such as encoding and
comprehension, but must also consider how the PWL impacts
attention. A starting point for creating an effective PWL should be
to design a label whose placement and label characteristics are
likely to attract attention. Only after such a label is developed, can
its impact be refined by subtle changes to wording or legibility.
Materials and Methods
Treatments
Five color combinations of PWL were used in this study (see
Figure 1a). Four of the five color combinations (i.e. black text on
blue, yellow, white and red backgrounds) were indicated by the
PharmexH (a commonly used PWL generation software) website to
be the most commonly used for English and Spanish PWL’s [44].
The fifth color combination, namely blue text on a white
background, was added at the request of a local pharmacist with
anecdotal information that indicated this combination to be
particularly problematic.
Prescription warning labels measuring 461 centimeters were
designed using AdobeH IllustratorH CS3. Five messages were
printed on the PWLs (see Figure 1a). Each message was evaluated
for reading ease using the Flesch-Kincaid reading-ease score, a test
that is widely used to assess readability [45]. All messages used had
a reading score of exactly 66.7, indicating that they could be easily
read by most 13–15 year olds.
Vials
PWLs were attached in vertical position to 10 dram vials with a
1-clicH type closure (Figure 1a). Previous publications have
indicated this vial size to be the most commonly used in the
Information Processing and Aging Patients
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United States [46]. Along with the vertically placed PWL’s, the
vials also contained a standard, white, pharmacy label which was
generated by the campus pharmacy that included: dosage, drug
and patient information (see Figure 1b).
All work was conducted in accordance with procedures
approved by the Michigan State University SIRB under ‘‘IRB
#08-246, The effect of color contrast of text on the legibility and
noticeability of prescription drugs’’ using an informed consent
process that employed both written and verbal consent.
Eye Tracking
An Applied Science Laboratories (ASL - Boston, MA) Model
501H Head Mounted Optics bright-pupil eye tracker was used to
track the gaze trail of subjects as they examined the prescription
vials. Eye tracking data was collected in the form of video files and
analyzed using Gaze TrackerH Eye Tracking analysis software.
During analysis, each vial was coded into three distinct ‘‘zones:’’
the white pharmacy label, the PWL, and the upper surface of the
white cap (see Figure 1b). Subjects were seated at a special table
fixtured with a pane of a glass and a chin rest (see Figure 5). This
setup allowed subjects to examine packages at a fixed distance
from their eyes, minimizing parallax error and enhancing
accuracy of the tracking of the gaze trail on the package surface,
providing insight into the attentive behavior of the subject.
Subjects were given the following scenario, ‘‘You have just been
delivered prescription medications from the pharmacy. Please do
what you would normally do. Feel free to examine the vials as you
please.’’ Following this instruction, subjects were handed five
pharmacy bags, one by one, each containing a single vial that
included a PWL in one of the five color contrasts. The order of
presentation (by PWL color contrast combination) was random-
ized to prevent confounding with run order. Subjects were allowed
to view the vials for as long, or as little, as they wished while
wearing the eye tracker, but were asked to press the package
against the calibrated pane of glass while reading information on
the vials. For each label zone (white pharmacy label, PWL, and
cap) observed by a subject on a given vial, two dependent variables
were recorded, namely the number of times the eye gaze entered
the zone (i.e., ‘‘the number of gazes’’), and a binary response
indicating whether that zone was fixated or not. These variables
were obtained by analyzing the gaze trail using the gaze tracker
software and were recorded for each subject while viewing each
vial.
Recognition Memory
Once the eye tracking was complete, subjects were shown a
sheet with 10 PWLs in different color contrasts; five of the color
contrasts were identical to the ones they had just viewed on the
vials. The other five had the same warning text as the tested PWLs
but had different background colors. Subjects were asked to pick
out the labels that they had just viewed on the vials. This
constituted a test of recognition memory. Responses were coded in
a binary fashion (correctly identified as seen or not seen previously,
for a total of 10 possible correct responses).
Supplementary Testing
Subjects were further characterized using several standardized
tests. In particular, health literacy was tested using the Rapid
Estimate for Adult Literacy in Medicine – Reduced (REALM-R)
[33]. Also, visual acuity was determined using a Dow Corning
Opthalmics Near Point Visual Acuity Card and participants’ Red/
Green Color Blindness was characterized using pseudo isochro-
matic plates manufactured by Richmond ProductsH (Albuquerque,
New Mexico).
Statistical Analyses
General or generalized linear mixed models were fitted to each
response of interest using the MIXED or GLIMMIX procedures
of SAS, respectively (Version 9.2, SAS Institute, Cary, NC).
Details on the fixed effects fitted in the linear predictor are
described in the corresponding results section. The random effect
of subject nested within age group was incorporated into all
statistical models to explicitly account for subject-specific random
perturbations on the responses and to account for lack of
independence between multiple responses from a given subject.
Least square mean estimates and estimated standard errors (or
estimated confidence intervals) are reported. Comparisons of
interest were adjusted using Tukey-Kramer’s or Bonferroni’s
approach to avoid inflation of Type I error rate due to multiple
comparisons.
Limitations
It would be valuable to replicate these effects with a larger
sample size that includes a greater range of ages. Although our
sample size was rather limited, it granted enough statistical power
to detect differences between the age groups we tested (18–29 and
Figure 5. Experimental set up (chin rest, calibrated plane and
the head-mounted optics of our ASL 501 eye tracking unit).
doi:10.1371/journal.pone.0038819.g005
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50+). A larger sample size is needed to generalize the best solutions
for standardization decisions.
Another potential concern is that we tested people’s memory for
the specific colors of the labels rather than the specific content on
the labels. While we recommend further study to probe
recognition memory of label content, there were a number of
reasons why we choose this approach. First, from a labeling
perspective we were interested in whether certain label colors were
more memorable or not. Second, within the memory literature
there is a distinction between memory judgments based on
familiarity and those based on recollection (for a review see
Yonelinas [47]). Within this distinction, recollection is the ability to
recall a specific episode or event during which information was
acquired, while familiarity is the sense that one has acquired the
information without specific knowledge of the circumstances under
which that information was acquired [48]. In the context of PWLs,
we were interested more in recollection memory than familiarity;
we wanted to assess not the general knowledge that one had
encountered a prescription labels that said ‘‘Do not consume
alcohol while taking this medication’’ but specific information
about the particular label/instance which had this warning. This
type of recollection memory is ‘‘operationally defined as recogni-
tion accompanied by…memory for a specific feature of the study
context, such as the location or color of an item.’’ [49] (p 251). In
addition this type of source memory requires deeper encoding of
the stimulus [47], and is the type of memory that is most degraded
in older people [50]. As such, the use of this form of memory test
allowed us to assess relatively thorough encoding of the message,
and probed a type of memory that older participants have the
most difficulty with. Thus our finding that memory performance
was no worse for older than younger subjects provided that both had
fixated the label, is even more striking and provides strong evidence
that labeling techniques which garner attention to PWLs may be
beneficial to the young and old alike.
Acknowledgments
The authors wish to express their deepest gratitude to Olin Pharmacy for
guidance regarding contrast combinations and the preparation of
pharmacy labels that contained realistic prescribing information and mock
patient and physician information.
Author Contributions
Conceived and designed the experiments: RPS LB NMB. Performed the
experiments: RPS. Analyzed the data: RPS LB NMB MWB. Wrote the
paper: RPS LB NMB MWB.
References
1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, et al. (1995) Incidence of
Adverse Drug Events and Potential Adverse Drug Events - Implications for
Prevention. Jama-Journal of the American Medical Association 274: 29–34.
2. Gryfebecker BM, Segal HJ, Einarson TR (1989) Effect of Auxiliary Prescription
Labels on the Elderly Ambulatory Patients Drug Knowledge. Dicp-the Annals of
Pharmacotherapy 23: 324–329.
3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Kelly K, et al. (2006)
Patterns of medication use in US adults and children, 2005: A report from the
slone survey. Pharmacoepidemiology and Drug Safety 15: S65–S66.
4. Davis TC, Michielutte R, Askov EN, Williams MV, Weiss BD (1998) Practical
assessment of adult literacy in health care. Health Education & Behavior 25:
613–624.
5. Davis TC, Wolf MS, Bass PF, Thompson JA, Tilson HH, et al. (2006) Literacy
and misunderstanding prescription drug labels. Annals of Internal Medicine 145:
887–894.
6. Bates DW (2007) Preventing medication errors: A summary. American Journal
of Health-System Pharmacy 64: S3–S9.
7. Boyd ST, Boyd LC, Zillich AJ (2006) Medication therapy management survey of
the prescription drug plans. Journal of the American Pharmacists Association 46:
692–699.
8. Rehder TL, Mccoy LK, Blackwell B, Whitehead W, Robinson A (1980)
Improving Medication Compliance by Counseling and Special Prescription
Container. American Journal of Hospital Pharmacy 37: 379–385.
9. Meredith S, Feldman P, Frey D, Hall K, Arnold K, et al. (2001) Possible
Medication Errors in Home Healthcare Patients. Journal of the American
Geriatrics Society 49: 719–724(716).
10. Aspden P, Institute of Medicine (U.S.). Committee on Identifying and
Preventing Medication Errors. (2007) Preventing medication errors. Washing-
ton, DC: National Academies Press. xvi, 463 p.
11. Berman A (2004) Reducing medication errors through naming labelling and
packaging. Journal of Medical Symptoms 28: 9–29.
12. Ault H (2007) A warning about prescription drug labels. McLean, VA.
13. Institute of Medicine (U.S.). Roundtable on Health Literacy., Hernandez LM,
Institute of Medicine (U.S.). Board on Population Health and Public Health
Practice. (2008) Standardizing medication labels : confusing patients less :
workshop summary. Washington, D.C.: National Academies Press. xv, 100 p.
14. United States Pharmacopeia (2010) Recommendations on Prescription Con-
tainer Labeling. United States Pharmacopeia.
15. Franklin D (2005) The Consumer: And Now, a Warning about Labels. The New
York Times. New Yor.
16. Wolf (2010) Improving Prescription Drug Warnings to Promote Patient
Comprehension (vol 170, pg 50, 2010). Archives of Internal Medicine 170:
608–608.
17. Davis T, Wolf M, Bass P, Middlebrooks M, Kennen E, et al. (2006) Low literacy
impairs comprehension of prescription drug warning labels. Journal of General
Internal Medicine 21: 847–851.
18. Bix L, Bello NM, Auras R, Ranger J, Lapinski MK (2009) Examining the
conspicuousness and prominence of two required warnings on OTC pain
relievers. Proceedings of the National Academy of Sciences of the United States
of America 106: 6550–6555.
19. Rogers WA, Rousseau G, Lamson N (1999) Maximizing the effectiveness of the
warning process: Understanding the variables that interact with age. In: Park
DC, Morrell RW, Shifren K, editors. Processing of medical information in aging
patients : cognitive and human factors perspectives. Mahwah, NJ: Lawrence
Erlbaum. pp. ix, 332 p.
20. Rousseau G, Lamson N (1998) Designing Warnings to Compensate for Age-
Related Changes in Perceptual and Cognitive Abilities. Psychology and
Marketing 15: 643–662.
21. Gurwitz J, Field T, Harrold L, Rothschild J, Debellis K, et al. (2002) Incidence
and preventability of adverse drug events among elderly patients in the
ambulatory setting. Gerontologist 42: 189–190.
22. Routledge PA, O’Mahony MS, Woodhouse KW (2004) Adverse drug reactions
in elderly patients. British Journal of Clinical Pharmacology 57: 121–126.
23. Sheikh A, Cresswell KM, Fernando B, McKinstry B (2007) Adverse drug events
in the elderly. British Medical Bulletin 83: 259–274.
24. Zelinsky G, Loschky L, Dickinson C (2011) Do object refixations during scene
viewing indicate rehearsal in visual working memory? Memory and Cognition
39: 600–613.
25. Yarbus A (1967) Eye Movements and Vision. New York City: Plenum Press.
26. Rayner K (1978) Eye movements in reading and information processing.
Psychological Bulletin 85: 618–660.
27. Rayner K (1998) Eye movements in reading and information processing: 20
years of research Psychological Bulletin 124.
28. Locher P (1996) The contribution of eye-movement research to an understand-
ing of the nature of pictorial balance perception: A review of the literature.
Journal of the International Assocation of Empirical Studies 14: 143–163.
29. Epelboim J, Suppes P, editors (1996) Window on the mind? What eye
movements reveal about geometric reasoning Mahwah, NJ: Erlbaum.
30. Ballard D, Hayhoe M, Pelz J (1995) Memory representations in natural tasks.
Journal of Cognitive Neuroscience 7: 66–80.
31. Mannan S, Ruddock K, Wooding D (1997) Fixation sequences made during
visual examination of briefly presented 2D images. Spatial Vision 11: 157–178.
32. Gilchrist I, Harvey M (2000) Refixation frequency and memory mechanisms in
visual search. Current Biology 10: 1209–1212.
33. Bass PF, Wilson JF, Griffith CH (2003) A shortened instrument for literacy
screening. Journal of General Internal Medicine 18: 1036–1038.
34. Godfrey SS, Allender L, Laughery KR, Smith VL (1983) Warning Messages:
Will the consumer bother to look?; Santa Monica, CA.
35. Goldhaber GM, Deturck MA (1989) A developmental analysis of warning signs:
the case of familiarity and gender. Proceedings of the Human Factors Society
33rd Annual Meeting.
36. Young SL, Martin EG, Wogalter MS (1991) Gender differences in consumer
product hazard perceptions. Proceedings of Interface 89: 73–78.
37. LaRue C, Cohen HH (1987) Factors affecting consumer perception of product
warnings: an examination of the differences between male and female
consumers. Proceedings of the Human Factors Society 35th Annual Meeting:
580–583.
38. Laughery KR, Vaubel KP, Young SL, Brelsford JW, Rowe AL (1993)
Explicitness of Consequence Information in Warnings. Safety Science 16:
597–613.
Information Processing and Aging Patients
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38819
39. Zuccollo G, Liddell H (1985) The Elderly and the Medication Label - Doing It
Better. Age and Ageing 14: 371–376.
40. Itti L, Koch C (2000) A saliency-based search mechanism for overt and covert
shifts of visual attention. Vision Research 40: 1489–1506.
41. Corbetta M, Shulman GL (2002) Control of goal-directed and stimulus-driven
attention in the brain. Nature Reviews Neuroscience 3: 201–215.
42. Posner MI, Petersen SE (1990) The Attention System of the Human Brain.
Annual Review of Neuroscience 13: 25–42.
43. Salthouse TA (2004) What and when of cognitive aging. Current Directions in
Psychological Science 13: 140–144.
44. Pharmex (2009) Top 40 Pharmex English and Spanish Warning Labels.
45. Flesch R (1948) A new readability yardstick. Journal of Applied Psychology 32:
221–233.
46. De La Fuente J (2006) The use of a universal design methodology for developing
child-resistant drug packaging. East Lansing: Michigan State University.
47. Yonelinas AP (2002) The nature of recollection and familiarity: A review of 30
years of research. Journal of Memory and Language 46: 441–517.
48. Ecker UKH, Zimmer HD, Groh-Bordin C (2007) Color and context: An ERP
study on intrinsic and extrinsic feature binding in episodic memory. Memory &
Cognition 35: 1483–1501.
49. Rugg MD, Curran T (2007) Event-related potentials and recognition memory.
Trends in Cognitive Sciences 11: 251–257.
50. Spencer WD, Raz N (1995) Differential effects of aging on memory for content
and context: A meta-analysis. Psychology and Aging 10: 527–539.
Information Processing and Aging Patients
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38819
